Literature DB >> 2741971

Methotrexate treatment in scleroderma.

F H van den Hoogen1, A M Boerbooms, L B van de Putte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2741971     DOI： 10.1016/s0002-9343(89)80499-1

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  The natural course of progressive systemic sclerosis patients with interstitial lung involvement.

Authors:  Musellim Benan; Ikitimur Hande; Ongen Gul
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

Review 2.  Effects of immunomodulating therapy in systemic sclerosis.

Authors:  F H van den Hoogen; A M Boerbooms; L B van de Putte
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo-controlled study.

Authors:  B Sharada; A Kumar; R Kakker; C M Adya; I Pande; S S Uppal; J N Pande; K R Sunderam; A N Malaviya
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 4.  Treatment of systemic sclerosis.

Authors:  T A Medsger
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 5.  [Methotrexate therapy in rheumatologic diseases--an update].

Authors:  Edmund Cauza; Attila Dunky
Journal:  Wien Med Wochenschr       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.